We investigated the immune checkpoint expression in glioma specimens and uncovered that CD274 (PD-L1), PDCD1, PDCD1LG2, CTLA4, CD276, HAVCR2, and LAG3 were significantly overexpressed in the high DDR score subtype (Figure 6B). This evidence concerns the gene CTLA4 and central nervous system cancer.